• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

HCR Manorcare

Quote




Not on the radar in terms of my competition. From what I hear they have a bad reputation in the industry, reps (even good ones) are given unrealistic goals and are shown the door when those goals aren't met.
 




Thanks! I have a feeling something is up bc they are constantly posting the same jobs. Must be a revolving door there. I didn't get a good vibe from my phone interview but will still go to the f2f to feel them out more.
 




Anonymous said:
Thanks! I have a feeling something is up bc they are constantly posting the same jobs. Must be a revolving door there. I didn't get a good vibe from my phone interview but will still go to the f2f to feel them out more.
Click to expand...

That seems to be the case in my neck of the woods. I applied for a hospice job with them last year, took them three months to make a decision (down to me and someone with previous hospice experience, they went with the latter). Since then I've seen the same job open three times. During the interview process the branch manager actually admitted to some botched service and asked how I might address it.
 
















Top Bottom
Back
Quote